8 patient evaluations for Abacavir-lamivudine (ABC/3TC)

Sort by: Most recent

Nov 23, 2020 (Started )

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
  • 0 helpful marks

Jun 23, 2014 (Started Feb 21, 2013)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 600 mg-300 mg Daily
  • 0 helpful marks

Aug 24, 2011 (Started May 06, 2011)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 600 mg-300 mg Daily
Cost: < $25 monthly
  • 0 helpful marks
Last updated:
Showing 3 of 8 patient evaluations for Abacavir-lamivudine (ABC/3TC)
See more data on Abacavir-lamivudine (ABC/3TC)